1051 related articles for article (PubMed ID: 16681663)
1. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
Cohen PR; Schulze KE; Nelson BR
Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
[TBL] [Abstract][Full Text] [Related]
2. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
3. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
4. Superficial basal cell carcinomas of the head and neck.
Mina MA; Picariello A; Fewkes JL
Dermatol Surg; 2013 Jul; 39(7):1003-8. PubMed ID: 23465089
[TBL] [Abstract][Full Text] [Related]
5. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
6. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):452-7. PubMed ID: 16112352
[TBL] [Abstract][Full Text] [Related]
7. Incidence of residual basal cell carcinoma in patients who appear tumor free after biopsy.
Holmkvist KA; Rogers GS; Dahl PR
J Am Acad Dermatol; 1999 Oct; 41(4):600-5. PubMed ID: 10495384
[TBL] [Abstract][Full Text] [Related]
8. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
9. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
[TBL] [Abstract][Full Text] [Related]
10. [Mohs micrographic surgery for repeat excision of basal cell carcinomas on the head with positive margins].
Angulo J; Serra-Guillén C; Traves V; Botella-Estrada R; Sanmartín O; Llombart B; Requena C; Guillén C; Nagore E
Actas Dermosifiliogr; 2011 Dec; 102(10):797-804. PubMed ID: 21684507
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
[TBL] [Abstract][Full Text] [Related]
12. [Mohs' method of micrographic surgery as treatment for recurrent basal cell carcinoma].
van Baardwijk AA; Verhaegh ME; Krekels GA; Vermeulen AH; Neumann HA
Ned Tijdschr Geneeskd; 1997 Mar; 141(11):524-9. PubMed ID: 9190509
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
Essers BA; Dirksen CD; Nieman FH; Smeets NW; Krekels GA; Prins MH; Neumann HA
Arch Dermatol; 2006 Feb; 142(2):187-94. PubMed ID: 16490846
[TBL] [Abstract][Full Text] [Related]
14. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma.
Paoli J; Daryoni S; Wennberg AM; Mölne L; Gillstedt M; Miocic M; Stenquist B
Acta Derm Venereol; 2011 Oct; 91(6):689-93. PubMed ID: 21681360
[TBL] [Abstract][Full Text] [Related]
15. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
[TBL] [Abstract][Full Text] [Related]
16. Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery.
Aoyagi S; Nouri K
Dermatol Surg; 2006 Nov; 32(11):1375-9. PubMed ID: 17083591
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous carcinoma with mixed histology: a potential etiology for skin cancer recurrence and an indication for Mohs microscopically controlled surgical excision.
Cohen PR; Schulze KE; Nelson BR
South Med J; 2005 Jul; 98(7):740-7. PubMed ID: 16108247
[TBL] [Abstract][Full Text] [Related]
18. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract][Full Text] [Related]
19. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
Florell SR; Layfield LJ; Gerwels JW
J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
[TBL] [Abstract][Full Text] [Related]
20. An assessment of incomplete facial Basal cell carcinoma excision.
Shah SA; Obaidullah ; Fahimullah
J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
